Cancer Pain

  • Abstral 2015 report

    Abstral 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 35 Pages The 5 Key Questions Addressed by this...

  • Fentora 2015 report

    Fentora 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 33 Pages The 5 Key Questions Addressed by this...

  • Lazanda 2015 report

    Lazanda 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 33 Pages The 5 Key Questions Addressed by this...

  • Opana 2015 report

    Opana 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by this...

  • OxyContin 2015 report

    OxyContin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by this...

  • Subsys 2015 report

    Subsys 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Abstral 2014 report

    Abstral 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...

  • Fentora 2014 report

    Fentora 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 32 Pages The 5 Key Questions Addressed by this...

  • Lazanda 2014 report

    Lazanda 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...

  • Opana 2014 report

    Opana 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...

  • OxyContin 2014 report

    OxyContin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 29 Pages The 5 Key Questions Addressed by this...

  • Subsys 2014 report

    Subsys 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...